Gyeonggi-do, South Korea

A Yeong Park

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: A Yeong Park: Innovator in Biotherapeutics

Introduction

A Yeong Park is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotherapeutics, holding a total of 7 patents. His work focuses on developing innovative compounds for the treatment of various medical disorders.

Latest Patents

Among his latest patents, one notable invention is related to substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors. This patent provides a compound of Formula (I) or pharmaceutically acceptable salts, along with methods for using the compound to treat disorders associated with HPK1. Another significant patent involves imidazopyridinyl compounds, which are aimed at treating neurodegenerative disorders. This patent also includes a compound of Formula (I) and outlines methods for preventing or treating neurodegenerative diseases.

Career Highlights

A Yeong Park is currently associated with 1st Biotherapeutics, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotherapeutics industry.

Collaborations

He collaborates with talented coworkers, including Jinhwa Lee and Suyeon Jo, to further enhance the impact of his research.

Conclusion

A Yeong Park's contributions to biotherapeutics through his patents and collaborations highlight his role as an influential inventor in the medical field. His ongoing work promises to lead to significant advancements in the treatment of various disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…